SHANGHAI, June 8, 2026 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Limited ("CORXEL"). Under the agreement, the Company has acquired the rights to […]

SAN DIEGO, June 8, 2026 /PRNewswire/ — Sapu Bioscience LLC announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) and the appointment of Global Clinical Trials (GCT) as the lead contract research organization supporting international execution of Study SP-03-B101. The announcement follows recent regulatory approvals supporting the study expansion […]

– Highlights the climate crisis facing the Himalayas and underscores the need for international solidarity and collective action – Held in Namche Bazaar, Nepal, the gateway to Mount Everest, underscoring a commitment to witnessing the climate crisis firsthand and translating awareness into action – Company also publishes sustainability report outlining efforts to foster a responsible […]

SHANGHAI, June 8, 2026 /PRNewswire/ — OriCell Therapeutics Holdings Limited ( The "Company" or "Oricell") , announced that its proprietary GPC3-targeted autologous CAR-T therapy, Ori-C101, has received clearance from China’s National Medical Products Administration (NMPA) to proceed into a confirmatory Phase II clinical trial in patients with GPC3-positive advanced hepatocellular carcinoma (HCC). The study is […]

HONG KONG, June 8, 2026 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the presentation of three key studies at the American Diabetes Association (ADA) 2026 Scientific Sessions (taking place June 5-8, 2026, in New Orleans, Louisiana), highlighting its differentiated portfolio in obesity treatment, including small-molecule candidates, a peptide therapeutic, and an oral peptide […]

SHANGHAI and HONG KONG, June 8, 2026 /PRNewswire/ — Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies indications, today announced that it has presented the first preclinical data on ATG-207, α […]

MAS Pathfinder Programme listing reflects Finnate’s governance-focused design and real-world deployment maturity across regulated financial services MELBOURNE, Australia, June 8, 2026 /PRNewswire/ — Centelon announced that Finnate, its enterprise automation platform for financial services, has been officially listed on the PathFin.ai Knowledge Hub — the primary AI solution registry under the Monetary Authority of Singapore (MAS) […]

NEW ORLEANS, June 8, 2026 /PRNewswire/ — Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences"), a commercial-stage biopharmaceutical company focused on discovering and developing innovative therapies for metabolic diseases, today announced that key data from a head-to-head study (SLIMMER-UP-SWITCH) evaluating ecnoglutide versus semaglutide was presented as a Late-Breaking abstract at the 86th Scientific Sessions of the […]